Nemera Announces Better Drug Deposition with RetroNose

nemera020519.jpg

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is presenting enhanced drug deposition results compared to classic nasal sprays with RetroNose.

 ALREADY A REGISTERED USER? SIGN IN now

Subscribe (for free) to read this article

In order to read this article, you must be a Packaging Europe subscriber. By becoming a subscriber, you get access to unmissable exclusive content like this, as well as enhanced personalisation options. The good news is that it’s completely free and very simple to subscribe - click the button below to learn more.

—>